Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)

Q: What does CUSIP 55083R104 represent in this 13F holders report?

CUSIP 55083R104 is the security identifier for LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in Q4 2021?

76 institutional investors reported LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 55083R104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 19,277,111
Total 13F shares: 85,540,866
Share change: +1,685,165
Total reported value: $662,180,000
Price per share: $7.74
Number of holders: 76
Value change: -$22,122,993
Number of buys: 50
Number of sells: 22

Quarterly Holders Quick Answers

What is CUSIP 55083R104?
CUSIP 55083R104 identifies LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 55083R104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of LYEL - Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MWG Management Ltd.	13F	Company	105%	20,298,522	$300,418,000	—	30 Sep 2021	13F
Apoletto Ltd	13F	Company	79%	15,167,757	$224,483,000	—	30 Sep 2021	13F
Foresite Capital Management IV, LLC	13F	Company	69%	13,282,181	$196,576,000	—	30 Sep 2021	13F
Alphabet Inc.	13F	Company	30%	5,865,125	$86,804,000	—	30 Sep 2021	13F
GSK plc	3/4/5	10%+ Owner	— class O/S missing	30,253,189	$68,977,271	—	21 Jun 2021	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	19%	3,659,270	$54,157,000	—	30 Sep 2021	13F
SB Management Ltd	13F	Company	18%	3,500,000	$51,800,000	—	30 Sep 2021	13F
HSG Holding Ltd	13F	Company	16%	3,045,997	$45,081,000	—	30 Sep 2021	13F
HHLR ADVISORS, LTD.	13F	Company	12%	2,348,965	$34,765,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	11%	2,212,819	$32,749,000	—	30 Sep 2021	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	8.5%	1,647,882	$24,389,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	7.4%	1,426,897	$21,118,000	—	30 Sep 2021	13F
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC	13F	Company	6.8%	1,320,000	$19,536,000	—	30 Sep 2021	13F
Dragoneer Investment Group, LLC	13F	Company	5.2%	1,000,000	$14,800,000	—	30 Sep 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	5.1%	975,190	$14,433,000	—	30 Sep 2021	13F
Artal Group S.A.	13F	Company	3.6%	700,000	$10,360,000	—	30 Sep 2021	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	3.1%	588,235	$8,706,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	2.8%	538,985	$7,978,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.8%	531,885	$7,871,000	—	30 Sep 2021	13F
FEDERATED HERMES, INC.	13F	Company	2.7%	519,000	$7,681,000	—	30 Sep 2021	13F
BROWN ADVISORY INC	13F	Company	2.4%	456,772	$6,760,000	—	30 Sep 2021	13F
BAILLIE GIFFORD & CO	13F	Company	2.2%	427,483	$6,327,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	2%	379,300	$5,614,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	1.8%	342,072	$5,063,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.5%	283,802	$4,200,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	1.1%	213,844	$3,165,000	—	30 Sep 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.1%	209,884	$3,106,000	—	30 Sep 2021	13F
Woodline Partners LP	13F	Company	1.1%	205,870	$3,047,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.97%	187,729	$2,778,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.86%	166,255	$2,461,000	—	30 Sep 2021	13F
Integral Health Asset Management, LLC	13F	Company	0.73%	140,000	$2,072,000	—	30 Sep 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.67%	128,535	$1,902,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.58%	112,640	$1,667,000	—	30 Sep 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.52%	100,000	$1,480,000	—	30 Sep 2021	13F
Eagle Health Investments LP	13F	Company	0.52%	100,000	$1,480,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.34%	65,515	$970,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.3%	58,618	$867,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.24%	45,798	$678,000	—	30 Sep 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.21%	40,658	$602,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.17%	32,015	$474,000	—	30 Sep 2021	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.15%	29,566	$438,000	—	30 Sep 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.1%	19,960	$295,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	16,889	$250,000	—	30 Sep 2021	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.08%	15,027	$222,000	—	30 Sep 2021	13F
Ghisallo Capital Management LLC	13F	Company	0.08%	15,000	$222,000	—	30 Sep 2021	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.08%	14,700	$218,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	13,596	$201,000	—	30 Sep 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.07%	12,934	$191,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.07%	12,769	$189,000	—	30 Sep 2021	13F
SG Americas Securities, LLC	13F	Company	0.06%	10,626	$157,000	—	30 Sep 2021	13F

Institutional Holders of Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) as of Q4 2021

As of 31 Dec 2021, Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,540,866 shares. The largest 10 holders included MWG Management Ltd., Apoletto Ltd, Foresite Capital Management IV, LLC, Alphabet Inc., PRICE T ROWE ASSOCIATES INC /MD/, SB Management Ltd, SC CHINA HOLDING Ltd, VANGUARD GROUP INC, BlackRock Inc., and Board of Trustees of The Leland Stanford Junior University. This page lists 76 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.